In consistent with previous findings, we demonstrate that the combination of small molecule inhibitors synergistically suppresses metastasis by modulating MMP-2 and MMP-9 expressions via TNF-α/AKT/NF-κB signaling in HPV-negative and HPV-positive HNSCC. The gene discussed is MMP9; the disease is head and neck squamous cell carcinoma.